Endocyte to Webcast Investor and Analyst Day in New York City
[at noodls] – WEST LAFAYETTE, Ind., March 18, 2013 (GLOBE NEWSWIRE) — Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics … more
View todays social media effects on ECYT
View the latest stocks trending across Twitter. Click to view dashboard